| Mr Jerry Lynn Reed Jr, APRN, FNP-C | |
|
7480 Ziegler Rd Ste 150, Chattanooga, TN 37421-4947 | |
| (423) 933-2001 | |
| (281) 816-3417 |
| Full Name | Mr Jerry Lynn Reed Jr |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 7480 Ziegler Rd Ste 150, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073158630 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Wesley Chapel | Wesley chapel, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Hospital Physician Group Inc | 2365679057 | 546 |
News Archive
The Associated Press: "A leading GOP negotiator on health care struck a further blow to fading chances of a bipartisan compromise by saying Democratic proposals would restrict medical choices and make the country's 'finances sicker without saving you money.' ... In the Republicans' weekly radio and Internet address on Saturday, [Sen. Mike] Enzi, D-Wyo., said any health care legislation must lower medical costs for Americans without increasing deficits and the national debt. 'The bills introduced by congressional Democrats fail to meet these standards,' he said."
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in disturbances that do not find medical explanation.
A new analysis indicates that higher body weight and taller stature during adolescence increase the risk of developing Non-Hodgkin's Lymphoma (NHL), a type of cancer of the lymphatic system. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.
› Verified 5 days ago
| Entity Name | Adventist Health System-sunbelt Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083692594 PECOS PAC ID: 0749232445 Enrollment ID: O20080401000861 |
News Archive
The Associated Press: "A leading GOP negotiator on health care struck a further blow to fading chances of a bipartisan compromise by saying Democratic proposals would restrict medical choices and make the country's 'finances sicker without saving you money.' ... In the Republicans' weekly radio and Internet address on Saturday, [Sen. Mike] Enzi, D-Wyo., said any health care legislation must lower medical costs for Americans without increasing deficits and the national debt. 'The bills introduced by congressional Democrats fail to meet these standards,' he said."
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in disturbances that do not find medical explanation.
A new analysis indicates that higher body weight and taller stature during adolescence increase the risk of developing Non-Hodgkin's Lymphoma (NHL), a type of cancer of the lymphatic system. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.
› Verified 5 days ago
| Entity Name | Florida Hospital Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174955256 PECOS PAC ID: 2365679057 Enrollment ID: O20131231000600 |
News Archive
The Associated Press: "A leading GOP negotiator on health care struck a further blow to fading chances of a bipartisan compromise by saying Democratic proposals would restrict medical choices and make the country's 'finances sicker without saving you money.' ... In the Republicans' weekly radio and Internet address on Saturday, [Sen. Mike] Enzi, D-Wyo., said any health care legislation must lower medical costs for Americans without increasing deficits and the national debt. 'The bills introduced by congressional Democrats fail to meet these standards,' he said."
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in disturbances that do not find medical explanation.
A new analysis indicates that higher body weight and taller stature during adolescence increase the risk of developing Non-Hodgkin's Lymphoma (NHL), a type of cancer of the lymphatic system. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.
› Verified 5 days ago
| Entity Name | Pioneer Medical Group Pl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710315775 PECOS PAC ID: 8224266655 Enrollment ID: O20140110000843 |
News Archive
The Associated Press: "A leading GOP negotiator on health care struck a further blow to fading chances of a bipartisan compromise by saying Democratic proposals would restrict medical choices and make the country's 'finances sicker without saving you money.' ... In the Republicans' weekly radio and Internet address on Saturday, [Sen. Mike] Enzi, D-Wyo., said any health care legislation must lower medical costs for Americans without increasing deficits and the national debt. 'The bills introduced by congressional Democrats fail to meet these standards,' he said."
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in disturbances that do not find medical explanation.
A new analysis indicates that higher body weight and taller stature during adolescence increase the risk of developing Non-Hodgkin's Lymphoma (NHL), a type of cancer of the lymphatic system. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jerry Lynn Reed Jr, APRN, FNP-C 431 D Ward Rd, Jonesborough, TN 37659-4808 Ph: (865) 313-6290 | Mr Jerry Lynn Reed Jr, APRN, FNP-C 7480 Ziegler Rd Ste 150, Chattanooga, TN 37421-4947 Ph: (423) 933-2001 |
News Archive
The Associated Press: "A leading GOP negotiator on health care struck a further blow to fading chances of a bipartisan compromise by saying Democratic proposals would restrict medical choices and make the country's 'finances sicker without saving you money.' ... In the Republicans' weekly radio and Internet address on Saturday, [Sen. Mike] Enzi, D-Wyo., said any health care legislation must lower medical costs for Americans without increasing deficits and the national debt. 'The bills introduced by congressional Democrats fail to meet these standards,' he said."
A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in disturbances that do not find medical explanation.
A new analysis indicates that higher body weight and taller stature during adolescence increase the risk of developing Non-Hodgkin's Lymphoma (NHL), a type of cancer of the lymphatic system. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.
› Verified 5 days ago